The hepatic loss of PCBP1 resulted in liver damage with steatosis (elevated liver triglycerides) and dying hepatocytes (elevated plasma alanine transaminase, ALT) (Protchenko et al., 2021). This evidence concerns the gene PCBP1 and steatosis.